Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Gemvax

2001 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer and manufacturer of pharmaceutical products. The company is focused on the development of peptide vaccines, which are innovative immunotherapeutic anti-cancer drugs.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • Teknologisenteret
  • Kjølnes Ring
  • 3918 Porsgrunn
  • Norway

Gemvax Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Gemvax‘s full profile, request access.

Request full access to PitchBook

Gemvax Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Gemvax‘s full profile, request access.

Request full access to PitchBook